ElevenLabs closed a $300m employee tender offer valuing the company at $22bn, it said on 30 September. That is double the valuation of its Series D in February, and it is a secondary transaction: employees sold existing shares, and the company itself received no new capital.
That distinction matters and is often lost. A tender sets a price without funding anything. What it does is let staff take money off the table and let large institutions buy in without the company diluting itself — which is a different signal from a primary round, and in some ways a cleaner one, because the buyers are paying for a stake rather than for growth they are financing.
Who bought
Wellington and T. Rowe Price led. Goldman Sachs, GIC, the Ontario Teachers’ Pension Plan, EQT Group, Sapphire Ventures and BDT & MSD Partners joined. Existing backers Andreessen Horowitz, Alkeon Capital, the D. E. Shaw Group, Disruptive, Evantic Capital, ICONIQ and Lightspeed also took part.
That is a list dominated by long-horizon institutional money rather than venture funds, which is what a company looks like when it is being priced as a business rather than as an option on one.
The number behind the number
ElevenLabs says enterprise now accounts for 55% of revenue, and that ElevenAgents, its platform for voice and chat agents, has more than tripled its annualised revenue since the Series D and now handles more than 15 million conversations a week.
That is the shift the valuation is tracking. ElevenLabs became known for synthetic narration sold to creators; what is now growing is a business selling agents that answer customer calls, which is a larger market with stickier contracts and a different competitive set.
What to watch
Whether the enterprise share keeps climbing past 55%, and whether a primary round follows. A company that can double its price without raising usually raises next at a number set by this one.
